Home › Waldenstrom Macroglobulinemia › Washington
Waldenstrom Macroglobulinemia clinical trials in Washington, DC
4 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi away
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- National Institute of Health, Bethesda · 7 mi away
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- Houston, TX6 studies
- New York City, NY6 studies
- Rochester, MN6 studies
- Dallas, TX6 studies
- Edison, NJ6 studies
- Seattle, WA5 studies
- Milwaukee, WI5 studies
- Baldwin Park, CA4 studies
- Columbus, OH4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.